Patent · US Active

CD86 variants with improved affinity for CTLA-4

US9834589B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

ALLIGATOR BIOSCIENCE AB · SE

Inventors

Peter Ellmark · Lund, SE
Christina Furebring · Lund, SE
Eva Dahlen · Lund, SE

Key dates

Filing date	Jun 25, 2014
Grant date	Dec 5, 2017
Priority date	—
Expiry date	Jun 25, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a polypeptide that specifically binds to CTLA-4, particularly human CTLA-4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.